98 / 132
Food and Drug Administration
98
Section 2. Globalization of Laboratory Testing
1. Food Field
(1) The
2014 International Conference on Food Testing Technology
was held on 30 October 2014.
Experts from the Swiss Official Food Control Authority and Eurofins of France were invited to share
their experiences and research outcomes on testing for adulterants in fruit juices, spices, and
other food products. About 200 people from county and local health bureaus, private laboratories,
universities and colleges, and other relevant testing institutions attended this Conference.
(2) In September 2014, TFDA attended the chemical expert work group meeting of the International Olive
Conference (IOC) held at Madrid, Spain, as a special guest to discuss the copper chlorophyll testing
method developed by Taiwan.
2. Medicinal Product Field
(1) In 2014, TFDA was invited to participate in the collaborative study of
Fifth WHO International Standard
for HCV for NAT-based assays.
(2) In October 2014, TFDA attended the 50
th
anniversary conference of the EDQM, and joined the poster
exhibition with posters entitled
Reference Standards for Biologics and in vitro diagnostics in Taiwan
and
Trends in the Pharmaceutical Adulterants in Dietary Supplements in Taiwan
. TFDA also visited
the laboratories of EDQM to gain information on the updates in the EU pharmacopoeia and Official
Medicinal Control Laboratory Network. This information will help to align Taiwan's medicinal products
testing specifications and methods with the intenartional trends as well as strength international
collaboration for the standards establishment.
(3) TFDA traveled to Maryland in the United States to attend the
17
th
Annual Conference on Vaccine
Research
organized by the National Foundation for Infectious Diseases (NFID) held at the end of
April 2014 to understand the latest information and trends in the development of emerging vaccines,
management and safety assessments of adjuvant vaccines, and current status of research for new
influenza vaccine being carried out in Europe, the United States, and other developed countries.
(4) The National Pharmaceutical Control Bureau (NPCB) of the Ministry of Health of Malaysia dispatched
two officials to TFDA in October 2014 for the two purposes of acquiring practical experiences on
medicinal products testing and management and carrying out bilateral exchange between the two
countries.
3. Medical Devices Field
In November 2014, TFDA visited Covidien's surgical-use medical device manufacturing plant as well
as Johnson & Johnson's contact lens manufacturing plant in the United States to study quality testing
and verification technologies for medical devices.
4. Cosmetics Field
In September 2014, TFDA was invited to attend the
International Conference for Regulatory
Harmonization for Cosmetics and Cosmetic Nanotechnology Management
to offer a presentation
titled
Achievements in Cosmetics Research and Analysis in Taiwan.